Ocugen (OCGN) Share-based Compensation Growth (5y) (2019 - 2026)
Ocugen (OCGN) Share-based Compensation Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.47% |
| Dec 31, 2025 | -43.10% |
| Sep 30, 2025 | 73.41% |
| Jun 30, 2025 | 49.26% |
| Mar 31, 2025 | 53.39% |
| Dec 31, 2024 | 26.55% |
| Sep 30, 2024 | 57.86% |
| Jun 30, 2024 | 76.18% |
| Mar 31, 2024 | 33.51% |
| Dec 31, 2023 | 39.27% |
| Sep 30, 2023 | -2.76% |
| Jun 30, 2023 | 45.19% |
| Mar 31, 2023 | 46.17% |
| Dec 31, 2022 | 50.99% |
| Sep 30, 2022 | 46.56% |
| Jun 30, 2022 | 41.15% |
| Mar 31, 2022 | 46.31% |
| Dec 31, 2021 | 71.57% |
| Sep 30, 2021 | 25.36% |
| Jun 30, 2021 | 44.20% |